Liquid Biopsy Market
The liquid biopsy market was valued at US$ 5.1 Billion in 2023, and is expected to register a CAGR of 16.8% over the forecast period and reach US$ 20.6 Bn in 2032....
Ebstein’s Anomaly Treatment Market
The Ebstein’s anomaly treatment market size reached US$ 13.72 billion in 2023. The market to reach US$ 27.89 billion by 2032, exhibiting a growth rate (CAGR) of 8.2% during 2024-2032....
Dilated Cardiomyopathy Treatment Market
The dilated cardiomyopathy treatment market size reached US$ 419.2 million in 2023. The market to reach US$ 591.5 million by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032....
Urine Bag Market
The urine bag market size reached US$ 1,899.3 million in 2023. The market will reach US$ 2,798.3 million by 2032, exhibiting a growth rate (CAGR) of 4.4% from 2024-2032....
Barlow's Syndrome Treatment Market
The barlow's syndrome treatment market size reached US$ 182.8 million in 2023. The market to reach US$ 387.3 million in 2032, exhibiting a growth rate (CAGR) of 8.7% during 2024-2032....
Critical Limb Ischemia (CLI) Treatment Market
The critical limb ischemia (CLI) treatment market size reached US$ 2.1 billion in 2023. The market to reach US$ 4.1 billion in 2032, exhibiting a growth rate (CAGR) of 7.8% during 2024-2032....
Interstitial Lung Disease Treatment Market
The global interstitial lung disease treatment market size reached US$ 1.3 billion in 2023. The market to reach US$ 2.0 million in 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032....
Familial Chylomicronemia Syndrome (FCS) Treatment Market
The Familial Chylomicronemia Syndrome (FCS) treatment market size reached US$ 15.4 million in 2023. The market to reach US$ 19.2 million in 2032, exhibiting a growth rate (CAGR) of 2.5% during 2024-2032....
Psoriatic Arthritis (PsA) Treatment Market
The Psoriatic Arthritis (PsA) treatment market size reached US$ 10.8 billion in 2023. The market to reach US$ 20.5 billion in 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032....
Checkpoint Inhibitor Refractory Cancer Treatment Market
The checkpoint inhibitor refractory cancer treatment market size reached US$ 35.6 billion in 2023. The market to reach US$ 89.6 billion in 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032....